PEGylated Protein Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014575981
Market Monitor Global
Oct-2021
Life Sciences
90 Pages

This report contains market size and forecasts of PEGylated Protein Therapeutics in Global, including the following market information:
Global PEGylated Protein Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global PEGylated Protein Therapeutics market was valued at 10010 million in 2020 and is projected to reach US$ 11600 million by 2027, at a CAGR of 3.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PEGylated Protein Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PEGylated Protein Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global PEGylated Protein Therapeutics Market Segment Percentages, By Type, 2020 (%)
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others

China PEGylated Protein Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China PEGylated Protein Therapeutics Market Segment Percentages, By Application, 2020 (%)
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others

Global PEGylated Protein Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global PEGylated Protein Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total PEGylated Protein Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total PEGylated Protein Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck
Pfizer
UCB
Amgen
AstraZeneca
Biogen
Roche
Horizon Pharma
Leadiant Biosciences

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 PEGylated Protein Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PEGylated Protein Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PEGylated Protein Therapeutics Overall Market Size
2.1 Global PEGylated Protein Therapeutics Market Size: 2021 VS 2027
2.2 Global PEGylated Protein Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PEGylated Protein Therapeutics Players in Global Market
3.2 Top Global PEGylated Protein Therapeutics Companies Ranked by Revenue
3.3 Global PEGylated Protein Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 PEGylated Protein Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies PEGylated Protein Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 PEGylated Protein Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 PEGylated Protein Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 PEGylated Protein Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global PEGylated Protein Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Colony Stimulating Factor
4.1.3 Interferon
4.1.4 Erythropoietin (EPO)
4.1.5 Recombinant Factor VIII
4.1.6 Monoclonal Antibody
4.1.7 Enzyme
4.1.8 Others
4.2 By Type - Global PEGylated Protein Therapeutics Revenue & Forecasts
4.2.1 By Type - Global PEGylated Protein Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global PEGylated Protein Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global PEGylated Protein Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PEGylated Protein Therapeutics Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Autoimmune Disease
5.1.4 Hepatitis
5.1.5 Multiple Sclerosis
5.1.6 Hemophilia
5.1.7 Gastrointestinal Disorder
5.1.8 Others
5.2 By Application - Global PEGylated Protein Therapeutics Revenue & Forecasts
5.2.1 By Application - Global PEGylated Protein Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global PEGylated Protein Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global PEGylated Protein Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global PEGylated Protein Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global PEGylated Protein Therapeutics Revenue & Forecasts
6.2.1 By Region - Global PEGylated Protein Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global PEGylated Protein Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global PEGylated Protein Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America PEGylated Protein Therapeutics Revenue, 2016-2027
6.3.2 US PEGylated Protein Therapeutics Market Size, 2016-2027
6.3.3 Canada PEGylated Protein Therapeutics Market Size, 2016-2027
6.3.4 Mexico PEGylated Protein Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe PEGylated Protein Therapeutics Revenue, 2016-2027
6.4.2 Germany PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.3 France PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.4 U.K. PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.5 Italy PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.6 Russia PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries PEGylated Protein Therapeutics Market Size, 2016-2027
6.4.8 Benelux PEGylated Protein Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia PEGylated Protein Therapeutics Revenue, 2016-2027
6.5.2 China PEGylated Protein Therapeutics Market Size, 2016-2027
6.5.3 Japan PEGylated Protein Therapeutics Market Size, 2016-2027
6.5.4 South Korea PEGylated Protein Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia PEGylated Protein Therapeutics Market Size, 2016-2027
6.5.6 India PEGylated Protein Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America PEGylated Protein Therapeutics Revenue, 2016-2027
6.6.2 Brazil PEGylated Protein Therapeutics Market Size, 2016-2027
6.6.3 Argentina PEGylated Protein Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PEGylated Protein Therapeutics Revenue, 2016-2027
6.7.2 Turkey PEGylated Protein Therapeutics Market Size, 2016-2027
6.7.3 Israel PEGylated Protein Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia PEGylated Protein Therapeutics Market Size, 2016-2027
6.7.5 UAE PEGylated Protein Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck PEGylated Protein Therapeutics Major Product Offerings
7.1.4 Merck PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer PEGylated Protein Therapeutics Major Product Offerings
7.2.4 Pfizer PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 UCB
7.3.1 UCB Corporate Summary
7.3.2 UCB Business Overview
7.3.3 UCB PEGylated Protein Therapeutics Major Product Offerings
7.3.4 UCB PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.3.5 UCB Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen PEGylated Protein Therapeutics Major Product Offerings
7.4.4 Amgen PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.4.5 Amgen Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PEGylated Protein Therapeutics Major Product Offerings
7.5.4 AstraZeneca PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 Biogen
7.6.1 Biogen Corporate Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen PEGylated Protein Therapeutics Major Product Offerings
7.6.4 Biogen PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.6.5 Biogen Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche PEGylated Protein Therapeutics Major Product Offerings
7.4.4 Roche PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.7.5 Roche Key News
7.8 Horizon Pharma
7.8.1 Horizon Pharma Corporate Summary
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma PEGylated Protein Therapeutics Major Product Offerings
7.8.4 Horizon Pharma PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.8.5 Horizon Pharma Key News
7.9 Leadiant Biosciences
7.9.1 Leadiant Biosciences Corporate Summary
7.9.2 Leadiant Biosciences Business Overview
7.9.3 Leadiant Biosciences PEGylated Protein Therapeutics Major Product Offerings
7.9.4 Leadiant Biosciences PEGylated Protein Therapeutics Revenue in Global (2016-2021)
7.9.5 Leadiant Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. PEGylated Protein Therapeutics Market Opportunities & Trends in Global Market
Table 2. PEGylated Protein Therapeutics Market Drivers in Global Market
Table 3. PEGylated Protein Therapeutics Market Restraints in Global Market
Table 4. Key Players of PEGylated Protein Therapeutics in Global Market
Table 5. Top PEGylated Protein Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global PEGylated Protein Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global PEGylated Protein Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies PEGylated Protein Therapeutics Product Type
Table 9. List of Global Tier 1 PEGylated Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PEGylated Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE